Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

OBJECTIVES: To compare responses in patients with early rheumatoid arthritis (RA) initially treated with the tumour necrosis factor inhibitor (TNFi) adalimumab+methotrexate (MTX) versus MTX monotherapy who may have continued receiving MTX or switched to adalimumab rescue therapy after inadequate res...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867415/
https://www.ncbi.nlm.nih.gov/pubmed/29146743
http://dx.doi.org/10.1136/annrheumdis-2017-211871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867415/
https://www.ncbi.nlm.nih.gov/pubmed/29146743
http://dx.doi.org/10.1136/annrheumdis-2017-211871

Ejemplares similares